Gene: ZCCHC2
Official Full Name: zinc finger CCHC-type containing 2provided by HGNC
Gene Summary: Predicted to enable nucleic acid binding activity; phosphatidylinositol binding activity; and zinc ion binding activity. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12450 | ZCCHC2 Knockout cell line (HeLa) | Human | ZCCHC2 | 1:3~1:6 | Negative | Online Inquiry |
KO12451 | ZCCHC2 Knockout cell line (HCT 116) | Human | ZCCHC2 | 1:2~1:4 | Negative | Online Inquiry |
KO12452 | ZCCHC2 Knockout cell line (HEK293) | Human | ZCCHC2 | 1:3~1:6 | Negative | Online Inquiry |
KO12453 | ZCCHC2 Knockout cell line (A549) | Human | ZCCHC2 | 1:3~1:4 | Negative | Online Inquiry |
ZCCHC2 Gene Knockout Cell Lines are specialized cellular models generated through advanced CRISPR-Cas9 genome-editing technology to specifically disrupt the ZCCHC2 gene. This gene encodes for a zinc finger protein involved in various biological processes, including RNA metabolism, protein synthesis regulation, and cellular signaling pathways. By creating knockout variants of these cell lines, researchers can delve deeper into the gene's functional roles, elucidating its contributions to cellular processes and disease mechanisms.
The primary function of ZCCHC2 Gene Knockout Cell Lines lies in their utility for examining the phenotypic consequences of ZCCHC2 gene disruption. Researchers can investigate changes in cellular behavior, assess metabolic pathways, and explore alterations in gene expression profiles, thereby uncovering invaluable insights regarding the gene's involvement in pathophysiological conditions, such as cancer and neurological disorders. These models are vital for both basic research and the development of therapeutic strategies aimed at targeting ZCCHC2-related pathways.
In comparison to other knockout models, ZCCHC2 Gene Knockout Cell Lines offer precise gene disruption with minimized off-target effects, thanks to their CRISPR-based design. Their reliable performance enables reproducibility in experiments, a crucial factor for validating scientific results. Furthermore, these cell lines are tailored for adaptability in various experimental applications, including high-throughput screening and functional assays, ensuring they meet diverse research needs.
For researchers and clinicians, ZCCHC2 Gene Knockout Cell Lines represent a powerful tool for advancing our understanding of genetic functions and their implications in disease. By leveraging this product, users gain access to a robust platform capable of supporting innovative investigations and therapeutic developments.
Our company specializes in producing high-quality biological research tools, and our expertise in gene editing and cell line development ensures that ZCCHC2 Gene Knockout Cell Lines meet stringent scientific standards, providing the reliability and innovation needed in today's research environment.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.